Skip to main content
Clinical Trials/NCT06853054
NCT06853054Not yet recruitingNot Applicable

A New Approach to Vascular Reconstruction Using Graphical 3D Printing and Flow Modelling to Create Personalized Precision Engineered Surgery

The Hospital for Sick Children1 site in 1 country30 target enrollmentStarted: September 1, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
30
Locations
1
Primary Endpoint
Survival Rate (%): patient status (Alive/Dead)

Study Overview

Brief Summary

Vascular Reconstruction is one of the most challenging areas of surgery, the surgeon has to create a completely watertight reconstruction without any narrowing or deformity that will restore normal flow characteristics, even at high pressures. Nowhere is this more challenging than in neonatal heart surgery where babies born with aortic arch narrowing or underdevelopment are one of the commonest life-threatening cardiovascular conditions.

Reconstruction not only has to recreate normal anatomy but also allow for subsequent growth and development.

Until now, surgical reconstruction depended on the surgeon's subjective assessment of the anatomy and a best estimate of patch shaping and design. New engineering techniques have enabled us to create 3D printed models of real hearts and then recreate the actual surgery on these models using a variety of engineered patches and different surgical techniques. These reconstructed models can now be placed in flow-testing rigs and undergo 4-dimensional flow imaging to provide high-fidelity velocity and shear force analysis that allow for precision design of the ideal geometry to give optimal flow.

This project will combine the skills of the largest team of neonatal heart surgeons in Canada, working with cardiac imaging experts, physicists and biomechanical engineers who are recognized as the world leaders in 3D printing technologies for congenital heart disease. Using a series of rigorous repeated tests and different designs we will define the ideal techniques and patch shapes and then translate this to real cases where a precision-shaped personalized patch can be created for each individual. Following up these babies as they grow with precision 3D scanning will show how these vessels are growing. Our mathematics-driven approach will make the surgery easier, shorter and more efficient. It will also provide more consistent surgical results among surgeons.

Detailed Description

Aortic arch reconstruction complications can be prevented or minimalized by personalizing the surgical technique and patch through mathematical computer modeling and 3D printing.

This is a feasibility study on the use of graphical 3D printing and flow modelling in the creation of personalized patch templates for the Norwood procedure and aortic arch reconstruction.

Patients undergoing the Norwood procedure as part of standard of care will be approached for consent. Patients who consent to the study will undergo a pre-operative contrast CT scan to design simulation models and to identify the most ideal aortic arch configuration. 3D printing of the sterilizable template will be done after computer-aided design of bespoke surgical patches and will be based on pre-operative imaging and simulation. The sterilizable patch template will be used by the surgeon as a guide to fashioning the precise size and shape of the patch.

A research CT scan will be done post-operatively, prior to patient discharge. The post-op CT scan will be used to create a 3D printed model of the reconstructed aortic arch, This 3D printed model will then undergo 4D MRI scanning as part of the analysis.

Patients will be monitored and followed closely post-surgery. They will be assessed by routine post-operative tests including standard of care imaging at 4-6 months after surgery.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
0 Months to 2 Months (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Newborns, 0-2 months of age
  • •Requiring a Norwood procedure and aortic arch reconstruction
  • •Consent provided

Exclusion Criteria

  • •Consent not provided
  • •Contraindications to contrast CT scans (allergy to contrast, kidney disease)
  • •Any condition or diagnosis, that could in the opinion of the Principal Investigator or delegate interfere with the participant's ability to comply with the study, might confound the interpretation of the study results, or put the participant at risk

Arms & Interventions

Personalized Patch Template

Experimental

Using each participant's pre-operative imaging, the most ideal aortic arch configuration will be identified. This will be followed by simulation of mechanical effects on the adjacent structures by overlapping the designed aortic arch model on the participant's original images. Computer-aided design of the personalized patch template will then be completed and followed by 3D printing of the sterilizable, personalized patch template.

Intervention: Personalized patch template (Procedure)

Outcomes

Primary Outcomes

Survival Rate (%): patient status (Alive/Dead)

Time Frame: In hospital, at 30 days and at 1 year follow-up

Survival will be recorded based on patient status at the time of discharge (in-hospital), 30 days post-surgery, and at 1-year follow-up. The unit of measure will be the percentage of patients who remain alive at each of these time points.

Hemodynamic Stability: Inotrope Requirement (daily score)

Time Frame: Post-op Day 1: Initial assessment within 24 hours of surgery, Post-op Days 2-7: Daily assessments during the first week post-surgery, 1 month, 6 months, 1 year follow up: Evaluation of ongoing hemodynamic stability

A scale measuring the need for inotropic support, based on the number and type of inotropic medications required. Inotropic support will be quantified on a daily score (ranging from 0 to a maximum score depending on inotrope usage).

Hemodynamic Stability: Blood pressure

Time Frame: Post-op Day 1: Initial assessment within 24 hours of surgery, Post-op Days 2-7: Daily assessments during the first week post-surgery, 1 month, 6 months, 1 year follow up: Evaluation of ongoing hemodynamic stability

Measured in mmHg using a standard non-invasive sphygmomanometer or an arterial catheter for continuous measurement in the ICU.

Hemodynamic Stability: Heart Rate

Time Frame: Post-op Day 1: Initial assessment within 24 hours of surgery, Post-op Days 2-7: Daily assessments during the first week post-surgery, 1 month, 6 months, 1 year follow up: Evaluation of ongoing hemodynamic stability

Measured in beats per minute (bpm) using ECG or pulse oximeter.

Hemodynamic Stability: Oxygen Saturations (SpO2)

Time Frame: Post-op Day 1: Initial assessment within 24 hours of surgery, Post-op Days 2-7: Daily assessments during the first week post-surgery, 1 month, 6 months, 1 year follow up: Evaluation of ongoing hemodynamic stability

Measured as a percentage (%) using a pulse oximeter.

Secondary Outcomes

  • Incidence of Structural Issues (Pulmonary or Bronchial Compression) (%)(At post-op Day 1 and at 1 month, 6 months and 1 year follow-up)
  • Flow velocity(At pre-op, post-op day 1, and at follow-up: a 1 month, 6 months and 1 year post surgery)
  • Cardiac Function (Ventricular Function and Valve Regurgitation) and Heart Structure (Atrial Septum Integrity)(At pre-op, post-op day 1, and at follow-up: a 1 month, 6 months and 1 year post surgery)
  • Growth Parameters at Follow-up: Weight(At hospital discharge, at 1 Month, 6 Months, and 1 Year follow-up)
  • Aortic Arch Dimensions (mm)(At pre-op, post-op day 1, and at follow-up: a 1 month, 6 months and 1 year post surgery)
  • Incidence of Post-operative Complications (%)(Post-op Days 1-3, Post-op days 4-7, Post Discharge (1 month, 6 months, 1 year))
  • Growth Parameters at Follow-up: Oxygen saturation in %(At hospital discharge, at 1 Month, 6 Months, and 1 Year follow-up)
  • Need for Re-intervention or Additional Surgeries (%)(During hospitalization, at 1 Month, 6 Months, and 1 Year Follow-up)
  • Long-term Reintervention or Complications(At 1 month, 6 months, and 1 year follow-up)
  • Growth Parameters at Follow-up: Height(At hospital discharge, at 1 Month, 6 Months, and 1 Year follow-up)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Shi-Joon Yoo

Staff Cardiac Radiologist, Division of Cardiac Imaging, Department of Diagnostic Imaging

The Hospital for Sick Children

Study Sites (1)

Loading locations...

Similar Trials